Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

March 31, 2016

Study Completion Date

April 30, 2016

Conditions

Healthy

Interventions

DRUG

Prevaglip (linagliptin)

1 tablet contains 5 mg linagliptin

DRUG

Trajenta (linagliptin)

1 tablet contains 5 mg linagliptin

Trial Locations (1)

Genuine Research Center GRC, Cairo